TipRanks
Scribe Therapeutics Inc. (SCTX)
NASDAQ:SCTX
US Market

Compare Scribe Therapeutics Inc. (SCTX) vs. Competitors

47 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Scribe Therapeutics Inc.
$28.44
$291.93M
―
-28.78%
4 Buy
0 Hold
0 Sell
Strong Buy
Arcturus Therapeutics
$8.85
$313.51M
-3.31
14.54%
7 Buy
2 Hold
0 Sell
Strong Buy
RegenXBio
$9.38
$475.29M
-1.90
-43.84%
9 Buy
2 Hold
0 Sell
Strong Buy
Editas Medicine
$3.28
$410.06M
-3.57
-11.30%
6 Buy
1 Hold
1 Sell
Moderate Buy
4D Molecular Therapeutics
$14.91
$657.41M
-4.38
5.12%
6 Buy
1 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.58
$856.10M
-4.29
8.51%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SCTX
Scribe Therapeutics Inc.
15.42
-6.23
-28.78%
ARCT
Arcturus Therapeutics
11.03
1.06
10.63%
RGNX
RegenXBio
7.20
-5.57
-43.62%
EDIT
Editas Medicine
2.67
-0.41
-13.31%
FDMT
4D Molecular Therapeutics
11.90
0.40
3.48%
PRME
Prime Medicine, Inc.
4.72
-0.22
-4.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts